Asterasys

아스테라시스 · 450950

Health Care Medical Devices · KOSDAQ

Small-cap

Market cap US$221.4M (₩305.5B)

Overview

Asterasys makes aesthetic medical devices that tighten and rejuvenate skin without surgery, supplying clinics and hospitals in South Korea and internationally.

Its flagship product, Liftera, uses high-intensity focused ultrasound, a technology that delivers targeted energy beneath the skin, and is designed to reduce treatment discomfort while improving results. Listed on KOSDAQ, South Korea's tech-focused small-cap exchange, the company earns the bulk of its revenue from the Liftera product line while expanding its portfolio with newly approved non-invasive radiofrequency devices.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025
Revenue · FY2025
US$27.5M
▲ +31.6% YoY
Operating profit · FY2025
US$7.5M
▲ +55.9% YoY
Net income · FY2025
US$6.7M
▲ +72.1% YoY

Revenue

  • FY2024US$20.9M
  • FY2025US$27.5M

Operating profit

  • FY2024US$4.8M
  • FY2025US$7.5M

Net income

  • FY2024US$3.9M
  • FY2025US$6.7M

Key ratios (FY2025)

ROE
19.7%
Debt/Eq
11.7%
Op. margin
27.4%
Net margin
24.3%
Rev. YoY
▲ +31.6%

Why it matters

New products have received approval from South Korea's MFDS, the national medical-device regulator, and are pursuing separate US FDA clearance to access international markets.

Price charts coming soon

Interactive price history isn't here yet. Would you use it?

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-06-12 (KST). · FX: 1 USD ≈ ₩1,380 (2026-06-01).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.